Takeda Pharmaceutical Co. Ltd. said in reporting its annual figures that it has to date not experienced any material impact on its financial results from the global coronavirus pandemic, despite various changes to its operations and working practices in line with the broader responses around the world.
Based on current information, Japan’s leading pharma company said it believes that its performance in the current fiscal year (ending 31 March 2021) “will not be materially affected
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?